Hyderabad: The city-based NephroPlus, Asia's dominant dialysis network, added another feather to its cap by expanding its footprint into the commonwealth of independent states (CIS) market. The company won the tender to build and operate a comprehensive dialysis programme for the Republic of Uzbekistan in a competitive international bidding process.
The 10-year project will be signed between the ministry of health of the Republic of Uzbekistan and NephroPlus. This high-value project is expected to generate revenue of Rs. 750-800 crores over the project term for NephroPlus.
The government of Uzbekistan awarded NephroPlus the bid to finance, construct, equip, train personnel, and operate four large dialysis centres in Tashkent, Karakalpakstan, and Khorezm region with an aim to deliver quality dialysis services for over 1,100 patients. With the need for dialysis care increasing every year, the Uzbekistan government has the right to add another 300 patients or more to this programme.
For this project, NephroPlus will establish a 100 per cent owned local subsidiary and the key resources from India will implement and supervise international standard clinical protocols to improve the quality of dialysis care in the country.
"It is a matter of pride for us that NephroPlus was the only bidder from Asia and this outcome proves that Indian healthcare firms can compete with and win amongst very large global incumbents. We look forward to serving the dialysis patients of Uzbekistan with the winning patient-centric model we have honed in India," said Vikram Vuppala, the founder and CEO of NephroPlus.
As part of this contract, NephroPlus will build the largest dialysis center in Asia to serve over 750 patients in the capital city of Tashkent. This new center at Tashkent will eclipse the current largest center in Asia which is also operated by NephroPlus at SVIMS University in Tirupathi, India. The project will also significantly benefit the rural patients as NephroPlus will introduce the first-ever home dialysis programme in the country. This programme will improve the quality of life among rural patients by reducing travel time and associated costs for patients.